CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia

There is an unmet need for markers that can stratify different forms and subtypes of dementia. Because of similarities in clinical presentation, it can be difficult to distinguish between Alzheimer's disease (AD) and frontotemporal dementia (FTD). Using a multiplex targeted proteomic LC-MS/MS p...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neurobiol Aging
Главные авторы: Heywood, Wendy E., Hallqvist, Jenny, Heslegrave, Amanda J., Zetterberg, Henrik, Fenoglio, Chiara, Scarpini, Elio, Rohrer, Jonathan D., Galimberti, Daniela, Mills, Kevin
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6221294/
https://ncbi.nlm.nih.gov/pubmed/30292090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neurobiolaging.2018.08.019
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы